A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

GSK5458514OngoingRecruitingPhase 1Open NCT06990880 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT06990880 · Trial Tracker · ComplyRx